Showing 1 - 1 results of 1 for search 'Nicolas S. H. Xander', query time: 0.02s Refine Results
  1. 1
    Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands

    Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands by Nicolas S. H. Xander, Nicolas S. H. Xander, W. Edward Fiets, Carin A. Uyl-de Groot, Carin A. Uyl-de Groot, Carin A. Uyl-de Groot

    Published 2023-06-01
    Get full text
    Article

Search Tools: